AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23313701 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 19
Study 21525259 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 31
Study 21525259 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 31
Study 19563093 — intervention group
Group type: EXPERIMENTAL
Intervention: Tara KLamp (TK) method
Number of subjects: 166
Study 19563093 — intervention group
Group type: COMPARATOR
Intervention: Forceps-guided (FG) method
Number of subjects: 166
Study 16683469 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening efforts with varied levels and frequencies of target sound and ambient noise
Number of subjects: 40
Study 16683469 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening efforts with varied levels and frequencies of target sound
Number of subjects: 40
Study 16683469 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-individual variation in earprints
Number of subjects: 40
Study 15286069 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback from a standardised assessment of need
Number of subjects: 304
Study 15286069 — intervention group
Group type: COMPARATOR
Intervention: No feedback (Control)
Number of subjects: 304
Study 11029005 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised treatment interruptions (one or two)
Number of subjects: 8
Study 9342132 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 19
Study 9342132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 8237807 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 12
Study 8237807 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 12
Study 8237807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3551674 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 101
Study 3551674 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 101
Study 29801739 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy (routine early coronary angiography and PCI)
Number of subjects: 881
Study 29801739 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 881
Study 28735031 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl
Number of subjects: 116
Study 28735031 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous fentanyl
Number of subjects: 116
Study 28735031 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular pethidine
Number of subjects: 116
Study 24665871 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation with ozonated water after subgingival scaling and root planing (SRP)
Number of subjects: 41
Study 24665871 — intervention group
Group type: COMPARATOR
Intervention: Subgingival scaling and root planing (SRP) followed by irrigation with distilled water
Number of subjects: 41
Study 23505301 — intervention group
Group type: EXPERIMENTAL
Intervention: Galectin-3 levels measured at baseline and 24 weeks
Number of subjects: 100
Study 23505301 — intervention group
Group type: EXPERIMENTAL
Intervention: Galectin-3 in patients with supramedian baseline LV ejection fraction (>49.2%)
Number of subjects: 100
Study 23505301 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline galectin-3 levels
Number of subjects: 100
Study 23505301 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of galectin-3 with matrix metalloproteinase-3 and monocyte chemoattractant protein-1
Number of subjects: 100
Study 21962393 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic HSCT after autologous HSCT (auto-allo group)
Number of subjects: 710
Study 21962393 — intervention group
Group type: COMPARATOR
Intervention: Tandem autologous HSCT (auto-auto group)
Number of subjects: 710
Study 21962393 — intervention group
Group type: COMPARATOR
Intervention: Maintenance therapy (thalidomide plus dexamethasone)
Number of subjects: 710
Study 21962393 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 710
Study 19142466 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual computerized remediation program (Play on) in students with developmental dyslexia (GIe)
Number of subjects: 20
Study 19142466 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual computerized remediation program (Play on) in good readers (GIIe)
Number of subjects: 20
Study 19142466 — intervention group
Group type: COMPARATOR
Intervention: No intervention in students with developmental dyslexia (GIc)
Number of subjects: 20
Study 19142466 — intervention group
Group type: COMPARATOR
Intervention: No intervention in good readers (GIIc)
Number of subjects: 20
Study 16382442 — intervention group
Group type: EXPERIMENTAL
Intervention: Ouabain infusion (0.4 mug.min(‐1).dl(‐1))
Number of subjects: 3
Study 16382442 — intervention group
Group type: COMPARATOR
Intervention: Control (no ouabain infusion)
Number of subjects: 3
Study 12805250 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched drink with essential vitamins and minerals (30% to 150% of RDA and higher levels of antioxidants), taken twice a day for six months
Number of subjects: 55
Study 12805250 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink, taken twice a day for six months
Number of subjects: 55
Study 12768686 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial laryngectomy with preoperative radiotherapy (dose 40-50Gy)
Number of subjects: 171
Study 12768686 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial laryngectomy with postoperative radiotherapy (dose 51-70 Gy)
Number of subjects: 171
Study 12768686 — intervention group
Group type: COMPARATOR
Intervention: Partial laryngectomy alone
Number of subjects: 171
Study 8816197 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 2065035 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg simvastatin q.a.m.
Number of subjects: 172
Study 2065035 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg simvastatin q.p.m.
Number of subjects: 172
Study 2065035 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg simvastatin q.a.m.
Number of subjects: 172
Study 2065035 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg simvastatin q.p.m.
Number of subjects: 172
Study 2065035 — intervention group
Group type: COMPARATOR
Intervention: Evening regimen (both dosages)
Number of subjects: 172
Study 2065035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 6127790 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with propantheline and antacids
Number of subjects: 67
Study 6127790 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with cimetidine and antacids
Number of subjects: 67
Study 6127790 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 67
Study 6127790 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal ulcer patients
Number of subjects: 67
Study 6127790 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 67
Study 6127790 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment (unspecified)
Number of subjects: 67
Study 31780277 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose indometacin (two 50 mg suppositories + placebo)
Number of subjects: 1037
Study 31780277 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose indometacin (three 50 mg suppositories + additional 50 mg after 4 hours)
Number of subjects: 1037
Study 31780277 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose indometacin
Number of subjects: 1037
Study 31780277 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose indometacin
Number of subjects: 1037
Study 30763131 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training program
Number of subjects: 30
Study 30763131 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 28093625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow dose CT (0.13 ± 0.01 mSv)
Number of subjects: 202
Study 28093625 — intervention group
Group type: COMPARATOR
Intervention: Standard dose CT (1.8 ± 0.7 mSv)
Number of subjects: 202
Study 26082615 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimasartan/HCTZ 12.5 mg
Number of subjects: 256
Study 26082615 — intervention group
Group type: COMPARATOR
Intervention: Fimasartan 60 mg
Number of subjects: 256
Study 24079295 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention including training in health centre management, fever case management with rapid diagnostic tests (RDTs) for malaria, patient-centered services, and provision of artemether-lumefantrine (AL) and RDTs.
Number of subjects: 20
Study 24079295 — intervention group
Group type: COMPARATOR
Intervention: Current standard of care (control group).
Number of subjects: 20
Study 22168805 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.84 mL of lidocaine with epinephrine plus 0.5 M mannitol
Number of subjects: 40
Study 22168805 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL of lidocaine with epinephrine plus 0.5 M mannitol
Number of subjects: 40
Study 22168805 — intervention group
Group type: COMPARATOR
Intervention: 1.8 mL of lidocaine with epinephrine (control solution)
Number of subjects: 40
Study 22168805 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine with epinephrine formulations without mannitol
Number of subjects: 40
Study 19630582 — intervention group
Group type: EXPERIMENTAL
Intervention: scent cues
Number of subjects: 20
Study 19630582 — intervention group
Group type: COMPARATOR
Intervention: no scent cues
Number of subjects: 20
Study 16495694 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecolic duodenojejunostomy
Number of subjects: 40
Study 16495694 — intervention group
Group type: COMPARATOR
Intervention: Retrocolic duodenojejunostomy
Number of subjects: 40
Study 14722590 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (8-hour program)
Number of subjects: 44
Study 14722590 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 nurses from the same unit)
Number of subjects: 44
Study 14722590 — intervention group
Group type: COMPARATOR
Intervention: Control group (19 nurses from a different unit)
Number of subjects: 44
Study 10874660 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface electromyography assessment in CLBP patients
Number of subjects: 30
Study 10874660 — intervention group
Group type: COMPARATOR
Intervention: Non-pain control subjects
Number of subjects: 30
Study 8443900 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon coarctation angioplasty
Number of subjects: 36
Study 8443900 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 36
Study 8443900 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 3533084 — intervention group
Group type: EXPERIMENTAL
Intervention: suprofen 200 mg/ml
Number of subjects: 60
Study 3533084 — intervention group
Group type: COMPARATOR
Intervention: lysine acetylsalicylate 0.9 g/2.5 ml
Number of subjects: 60
Study 30337745 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen drive aerosol inhalation with 2 mg budesonide and 60 mg ambroxol for 3 days before operation
Number of subjects: 80
Study 30337745 — intervention group
Group type: COMPARATOR
Intervention: Control group without preoperative aerosol inhalation
Number of subjects: 80
Study 30337745 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen drive aerosol inhalation with 2 mg budesonide and 60 mg ambroxol
Number of subjects: 80
Study 27048692 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial therapy in patients without intravenous alteplase treatment
Number of subjects: 55
Study 27048692 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial therapy in patients with intravenous alteplase treatment
Number of subjects: 55
Study 27048692 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety parameters and serious adverse events
Number of subjects: 55
Study 24329132 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose ultrasound (1.5 Watt/cm(2))
Number of subjects: 61
Study 24329132 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power pain threshold ultrasound (HPPT)
Number of subjects: 61
Study 24329132 — intervention group
Group type: COMPARATOR
Intervention: Low-dose ultrasound (0.5 W/cm(2))
Number of subjects: 61
Study 22522994 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 126
Study 22522994 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 126
Study 22522994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 21269038 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total (0.3% triclosan/2.0% PVM/MA copolymer/0.243% sodium fluoride)
Number of subjects: 75
Study 21269038 — intervention group
Group type: COMPARATOR
Intervention: Crest Pro-Health (0.454% stannous fluoride, sodium hexametaphosphate, zinc lactate)
Number of subjects: 75
Study 18449450 — intervention group
Group type: EXPERIMENTAL
Intervention: Low protein diet (LPD) 0.6-0.8 g/kg per day
Number of subjects: 60
Study 18449450 — intervention group
Group type: COMPARATOR
Intervention: Normal protein diet (NPD) 1.0-1.2 g/kg per day
Number of subjects: 60
Study 15616227 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 19
Study 15616227 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 19
Study 12721262 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% BCNU polymer
Number of subjects: 44
Study 12721262 — intervention group
Group type: EXPERIMENTAL
Intervention: 28% BCNU polymer
Number of subjects: 44
Study 12721262 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5%, 10%, 14.5% BCNU polymers
Number of subjects: 44
Study 10486676 — intervention group
Group type: EXPERIMENTAL
Intervention: Dippers
Number of subjects: 245
Study 10486676 — intervention group
Group type: COMPARATOR
Intervention: Non dippers
Number of subjects: 245
Study 8618369 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate antacid tablets (Tums, 1000 mg)
Number of subjects: 18
Study 8618369 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (Pepcid AC, 10 mg)
Number of subjects: 18
Study 8618369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 1565534 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily oral cefixime (8 mg/kg)
Number of subjects: 76
Study 1565534 — intervention group
Group type: COMPARATOR
Intervention: Twice daily oral trimethoprim/sulfamethoxazole (TMP/SMX) (8/40 mg/kg/day)
Number of subjects: 76
Study 1565534 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study 4084979 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level tension at 5% of individual maximum (Group 1)
Number of subjects: 48
Study 4084979 — intervention group
Group type: COMPARATOR
Intervention: High-level tension at 30% of individual maximum (Group 2)
Number of subjects: 48
Study 4084979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 48
Study 31564601 — intervention group
Group type: EXPERIMENTAL
Intervention: Tu Salud ¡Si Cuenta! (Your Health Matters!) at Home Intervention, 6 monthly CHW visits
Number of subjects: 500
Study 31564601 — intervention group
Group type: COMPARATOR
Intervention: Standard care (community‐wide health promotion campaign)
Number of subjects: 500
Study 29771700 — intervention group
Group type: EXPERIMENTAL
Intervention: IV amino acid supplementation (up to 100g daily to achieve 2.0g/kg/d)
Number of subjects: 474
Study 29771700 — intervention group
Group type: EXPERIMENTAL
Intervention: IV amino acid supplementation
Number of subjects: 474
Study 29771700 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 474
Study 27278405 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol- and fibre-rich foods (PFRF) - lower dose
Number of subjects: 16
Study 27278405 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol- and fibre-rich foods (PFRF) - higher dose
Number of subjects: 16
Study 27278405 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol- and fibre-rich foods (PFRF)
Number of subjects: 16
Study 27278405 — intervention group
Group type: COMPARATOR
Intervention: Control (bread, water, balancing sugars)
Number of subjects: 16
Study 24885551 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified inpatient DBT for 12 weeks plus six months of standard DBT
Number of subjects: 70
Study 24885551 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient DBT
Number of subjects: 70
Study 22298313 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification cataract surgery
Number of subjects: 30
Study 19887440 — intervention group
Group type: COMPARATOR
Intervention: Home exercise programme
Number of subjects: 70
Study 19887440 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise programme
Number of subjects: 70
Study 18519460 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand sanitizer and quaternary ammonium wipes for surface disinfection for 8 weeks
Number of subjects: 285
Study 18519460 — intervention group
Group type: COMPARATOR
Intervention: Usual hand-washing and cleaning practices
Number of subjects: 285
Study 18519460 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand sanitizer and quaternary ammonium wipes for surface disinfection
Number of subjects: 285
Study 16084125 — intervention group
Group type: COMPARATOR
Intervention: 50 mg melatonin
Number of subjects: 40
Study 16084125 — intervention group
Group type: COMPARATOR
Intervention: 5 mg melatonin
Number of subjects: 40
Study 16084125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11976989 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea and didanosine (PANDAs)
Number of subjects: 16
Study 11976989 — intervention group
Group type: COMPARATOR
Intervention: Highly active antiretroviral therapy (HAART)
Number of subjects: 16
Study 11976989 — intervention group
Group type: EXPERIMENTAL
Intervention: PANDAs
Number of subjects: 16
Study 11976989 — intervention group
Group type: COMPARATOR
Intervention: HAART
Number of subjects: 16
Study 10713863 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinogen (hyaluronic acid containing cream)
Number of subjects: 56
Study 10713863 — intervention group
Group type: COMPARATOR
Intervention: H.E.C. (ointment)
Number of subjects: 56
Study 7586621 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion (5 micrograms/kg/min i.v. for a median of 109 hours)
Number of subjects: 20
Study 7586621 — intervention group
Group type: COMPARATOR
Intervention: Dopamine infusion (continued)
Number of subjects: 20
Study 7586621 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine withdrawal
Number of subjects: 20
Study 7586621 — intervention group
Group type: COMPARATOR
Intervention: Dopamine infusion (continued and interrupted)
Number of subjects: 20
Study 1735342 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous drainage using ultrasound guidance followed by intralesional nitroimidazole administration
Number of subjects: 51
Study 1735342 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy with nitroimidazoles
Number of subjects: 51
Study 1735342 — intervention group
Group type: COMPARATOR
Intervention: Open surgical drainage
Number of subjects: 51
Study 6437487 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital rehabilitation
Number of subjects: 120
Study 6437487 — intervention group
Group type: COMPARATOR
Intervention: Control group (managed as before day hospital care)
Number of subjects: 120
Study 31618060 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil
Number of subjects: 14
Study 31618060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 29923977 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukosan SkinLink (LS)
Number of subjects: 49
Study 29923977 — intervention group
Group type: COMPARATOR
Intervention: Surgical suture (SS)
Number of subjects: 49
Study 27879183 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised self-management support using the SeMaS questionnaire
Number of subjects: 644
Study 27879183 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 644
Study 24269833 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.014in. NiTi wire
Number of subjects: 71
Study 24269833 — intervention group
Group type: COMPARATOR
Intervention: Rectangular NiTi wires
Number of subjects: 71
Study 24269833 — intervention group
Group type: COMPARATOR
Intervention: Bracket type
Number of subjects: 71
Study 22691136 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive defusion (CD)
Number of subjects: 110
Study 22691136 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restructuring (CR)
Number of subjects: 110
Study 22691136 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 110
Study 20581302 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical management, radiation therapy, and systemic therapy for pelvic bone sarcomas
Number of subjects: 0
Study 17593235 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glulisine (0.2 U/kg)
Number of subjects: 80
Study 17593235 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro (0.2 U/kg)
Number of subjects: 80
Study 17593235 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glulisine (0.4 U/kg)
Number of subjects: 80
Study 17593235 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro (0.4 U/kg)
Number of subjects: 80
Study 16279152 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported arm exercise (SAE)
Number of subjects: 8
Study 16279152 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupported arm exercise (UAE)
Number of subjects: 8
Study 16279152 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg exercise (LE)
Number of subjects: 8
Study 16279152 — intervention group
Group type: EXPERIMENTAL
Intervention: End-expiratory lung volume to total lung capacity ratio during SAE
Number of subjects: 8
Study 16279152 — intervention group
Group type: EXPERIMENTAL
Intervention: End-expiratory lung volume to total lung capacity ratio during LE
Number of subjects: 8
Study 12466870 — intervention group
Group type: COMPARATOR
Intervention: Proximal Femoral Nail (PFN)
Number of subjects: 250
Study 12466870 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma Nail
Number of subjects: 250